Press Contact
For media enquiries, please reach out to: contact@aspivix.com
All
- All
- Blog
- In the media
- Press releases
ASPIVIX – Manufacturer of non-traumatic medical devices for gynecology – closes $5M Series A+ Funding Round and receives a large EUREKA-EUROSTARS grant co-funded by Innosuisse, the Swiss Innovation Agency.
This funding round will accelerate market access in Europe and US, and finance clinical activities in the US, while the EUREKA EUROSTARS grant will fuel R&D’s activities to expand product offering. ASPIVIX,...
10 Simple Steps Gynecologists Can Take to Enhance Patient Experience
A visit to the gynecologist can be a daunting experience for many women. There are a lot of unknowns and it can be an emotionally charged atmosphere. Gynecologists must be aware of...
5 Common Myths About Contraceptives
Contraceptives, like pills and condoms, are some of the most commonly used medications in the world. But despite their popularity, there are a lot of misconceptions about them. In this blog post,...
A modern approach to women’s healthcare
European researchers have invented a new medical device to replace conventional forceps used routinely in gynaecological procedures for the past 100 years. The new gentle method offers a less painful experience to...
Clinical data show significantly lower IUD procedural pain and bleeding rates with Aspivix’s novel suction-based cervical device
GHENT, Belgium, May 25, 2022 /PRNewswire/ -- ASPIVIX SA, a developer of medical technologies to advance gynecological care, today announced positive results from its ADVANCE Women (Atraumatic Device using VAcuum Technology for CErvical Procedures in...
